Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic Diseases

This study has been completed.

Study NCT00519064 Information provided by Novartis

First Received: August 20, 2007 Last Updated: June 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)